Jesús Fuentes Antrás, MD, MSc, is a Medical Oncologist and Clinical Investigator in the NEXT Oncology Early Drug Development Unit at Hospital Universitario Quirónsalud Madrid. Dr. Fuentes Antrás received his MD with honors in 2015 from the Universidad Autónoma de Madrid. He completed his Medical Oncology training at Hospital Clínico San Carlos in Madrid, and subsequently joined the Drug Development and Breast Cancer Units at Princess Margaret Cancer Centre – University Health Network in Toronto, Canada, as a clinical research fellow. Dr. Fuentes Antrás holds a Master’s degree in Molecular Oncology and is a PhD candidate in Translational Research in breast cancer from the Universidad Complutense de Madrid. Dr. Fuentes Antrás has been recipient of early-career clinician and investigator merit awards from the Spanish Agency Against Cancer (AECC), the Spanish Society of Medical Oncology (SEOM), and the American Society of Clinical Oncology (ASCO), including a SEOM “Somos Futuro” for best medical oncology resident in the country, an ASCO Conquer Cancer Foundation Young Investigator Award, or a Novartis Young Canadian Investigator Award. His clinical practice is focused on the care of patients participating in phase I trials testing novel anti-cancer molecules and including first-in-human studies. Dr Fuentes Antrás’ research interests include early drug development, multi-omic profiling, circulating biomarkers, and preclinical research models with the goal of advancing precision medicine for cancer patients.
